0 0 0.00169734151329252 0.00169734151329252 0 0.00102249488752556 0.00102249488752556 0.00204498977505112
Sign Up Today X
Thanks for submitting the form.
Stockreport

Coronavirus Proves Drug Companies To Be Innovators [Forbes]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Forbes
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
In the midst of the COVID-19 pandemic, many Americans are concerned about loved ones in at-risk groups and the capacity of our hospitals and medical system to address those in need—all while making extraordinary efforts to follow social distancing and work-from-home guidelines. Perhaps the most important ongoing development of the coronavirus, however, is the research and development that drug companies are dedicating to discovering both treatments and vaccines. Some have argued that the pharmaceutical companies are taking advantage of the pandemic to make a quick buck, but that argument strains credulity. It is hard to understate how the pharmaceutical industry is doing its absolute best to find treatments as well as, possibly most importantly, a vaccine to the coronavirus during this time of national emergency. To me, it comes as little surprise that the US biopharmaceutical industry is leading the world right now in vaccines and treatments to COVID-19. To date, they have many clini [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

Coronavirus Proves Drug Companies To Be Innovators [Forbes]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Forbes
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
In the midst of the COVID-19 pandemic, many Americans are concerned about loved ones in at-risk groups and the capacity of our hospitals and medical system to address those in need—all while making extraordinary efforts to follow social distancing and work-from-home guidelines. Perhaps the most important ongoing development of the coronavirus, however, is the research and development that drug companies are dedicating to discovering both treatments and vaccines. Some have argued that the pharmaceutical companies are taking advantage of the pandemic to make a quick buck, but that argument strains credulity. It is hard to understate how the pharmaceutical industry is doing its absolute best to find treatments as well as, possibly most importantly, a vaccine to the coronavirus during this time of national emergency. To me, it comes as little surprise that the US biopharmaceutical industry is leading the world right now in vaccines and treatments to COVID-19. To date, they have many clini [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS